Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa-Reference-Cited by-同舟云学术

Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa

Published:2011-02 Issue:2 Volume:47 Page:104-107
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Paluszczak Jarosław,Misiak Paulina,Wierzbicka Małgorzata,Woźniak Aldona,Baer-Dubowska Wanda

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference32 articles.

1. Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review;Almadori;Eur J Cancer,2004

2. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue;Braakhuis;Oral Oncol,2010

3. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin;Slaughter;Cancer,1953

4. Loss of heterozygosity on chromosome arm 13q in larynx cancer patients: analysis of tumor, margin and clinically unchanged mucosa;Szukała;Med Sci Monit,2004

5. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma;Shaw;Br J Oral Maxillofac Surg,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated analysis of methylation and transcriptome identifies a novel risk model for diagnosis, prognosis, and immune characteristics in head and neck squamous cell carcinoma;Molecular Genetics and Genomics;2024-07-20

2. Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem;Cancers;2022-03-28

3. Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer;Frontiers in Oncology;2021-12-16

4. Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer;Cancers;2021-10-19

5. Epigenetically inactivated RASSF1A as a tumor biomarker;Bosnian Journal of Basic Medical Sciences;2020-11-11